Livit (Netherlands) Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 1,120
Employees
  • Latest Deal Type
  • Undetermined
  • Financing Rounds
  • 3
  • Investments
  • 1

Livit (Netherlands) General Information

Description

Manufacturer and supplier of orthopedic devices. The company provides orthopedic products such as prostheses, corsets, orthotics, fracture tires, redressiehelm and pro pace for its customers in the Netherlands.

Contact Information

Website
www.livit.nl
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Primary Office
  • Gyrospcoopweg 144
  • 1042 AZ Amsterdam
  • Netherlands
+31 088 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Livit (Netherlands) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Livit (Netherlands)‘s full profile, request access.

Request a free trial

Livit (Netherlands) Executive Team (2)

Name Title Board Seat Contact Info
Edze Tollenaar Chief Financial Officer
Gijs Ellens Managing Director
To view Livit (Netherlands)’s complete executive team members history, request access »

Livit (Netherlands) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Livit (Netherlands) Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000 & 22-Jun-2010 0000000000 Medical Supplies
To view Livit (Netherlands)’s complete investments history, request access »